CVR: 41193093
Organon Denmark ApS demonstrates a stable financial trajectory with consistent revenue growth, increasing from 49.2 million DKK in 2020 to 74.1 million DKK in 2024. Profitability has fluctuated, peaking at 2.9 million DKK in 2023 before declining to 2.4 million DKK in 2024, indicating potential concerns regarding profit margins. The company's equity position remains strong at 27.9 million DKK, although it has seen a slight decline from the previous year. Positioned within the wholesale trade of pharmaceuticals and healthcare products, Organon Denmark ApS appears to be a solid player in its industry, though attention to profit sustainability may be warranted.
AI-generated summary
Selskabets formål er at udøve virksomhed indenfor industri og handel samt al virksomhed, som efter direktionens skøn har forbindelse hermed.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 74.1 mio. | 2.4 mio. | 41.6 mio. | 27.9 mio. | 15 | |
Compared to 406 companies in Engroshandel med medicinalvarer og sygeplejeartikler
Comparison is based on industry median values
Sofia Raquel Paulos Ferreira Alves da Silva joined as director
Anne Bitzer joined as director
Isabel Vandenberk left as director
Karl Johan Sundt joined as director
Gitte Schou Petersen left as director
Companies in the same industry and area
CVR 41183144
CVR 35451307
CVR 36392398
CVR 14479880
CVR 29625867
companydata.dk